Tempus Executive and Leadership Team

Max Banaszak, the Chief Operating Officer, Data & Apps at Tempus, directs the operational execution of the company's data-driven software applications. Overseeing the internal processes that normalize and clean vast amounts of clinical information, the Chief Operating Officer ensures that the platform delivers accurate and timely insights to medical practitioners. This leadership role involves streamlining the workflow between laboratory sequencing and the digital application interface to maximize efficiency. By optimizing the data engine, Banaszak supports the company's mission to provide tailored therapeutic models for oncology and infectious diseases. The Chief Operating Officer also coordinates with technical teams to ensure that the software remains robust and scalable as the library of clinical data grows. Max Banaszak maintains a focus on operational excellence, driving the continuous improvement of the company's data products while ensuring that the organization meets the high demands of the modern healthcare ecosystem.

Monique Patrick, the Operations Executive & Chief Operating Officer, Supporting & Suite Executive at Tempus, directs the administrative and operational support functions that enable the company's core business activities. Overseeing the organizational infrastructure, the Chief Operating Officer ensures that internal teams have the resources necessary to advance the company's mission in precision medicine. This leadership role involves managing the operational workflows that support the executive suite and cross-departmental collaboration. By optimizing internal processes, Patrick facilitates the seamless integration of clinical data science and genomic diagnostics across the enterprise. The Chief Operating Officer also drives initiatives that improve organizational agility and efficiency in a fast-paced technology environment. Monique Patrick maintains a focus on operational stability, driving the support systems that allow the company to scale its impact on healthcare while ensuring that all business units remain aligned with the overarching strategic goals of the organization.

Natasha Esprey, the Chief Information Officer at Tempus, directs the enterprise-wide digital infrastructure required to process massive clinical and molecular datasets. Overseeing the secure integration of electronic health records, the Chief Information Officer ensures that internal systems maintain the highest standards of data integrity and regulatory compliance. This leadership role involves architecting scalable cloud environments that support the company's complex neural networks and predictive modeling engines. By optimizing the flow of unstructured text into actionable diagnostic profiles, Esprey enables medical practitioners to access critical patient insights with unprecedented speed. The Chief Information Officer also collaborates with engineering teams to refine the proprietary data engine, ensuring that the platform remains at the forefront of precision medicine. Natasha Esprey maintains a focus on operational efficiency, driving the technological advancements necessary to support global healthcare initiatives and the ongoing expansion of the company's clinical data library.

Patricia Spiller, the Chief Marketing Officer at Tempus, architects the strategic communication frameworks that position the company as a leader in artificial intelligence and genomic diagnostics. Overseeing global brand initiatives, the Chief Marketing Officer ensures that the value proposition of precision-based therapeutic models reaches oncology and cardiology practitioners across diverse markets. This leadership role involves translating complex clinical data science into compelling narratives that drive adoption of the proprietary software platform. By aligning marketing efforts with the company's mission to transform healthcare, Spiller expands the reach of the organization's diagnostic tools. The Chief Marketing Officer also manages cross-functional partnerships to highlight the impact of predictive data modeling on patient outcomes. Patricia Spiller maintains a focus on market penetration, driving the growth of the company's footprint in the healthcare ecosystem while ensuring that medical professionals understand the unique benefits of integrating molecular sequencing with clinical history.

Shane Colley, the Chief Technology Officer at Tempus, directs the development of the core algorithmic platform that powers the company's artificial intelligence and machine learning capabilities. Overseeing the engineering teams responsible for normalizing vast amounts of unstructured clinical data, the Chief Technology Officer ensures that the software platform remains capable of identifying invisible genetic patterns. This leadership role involves pushing the boundaries of predictive data modeling to uncover therapeutic correlations that assist doctors in choosing targeted treatments. By fostering innovation in neural network architecture, Colley enables the organization to maintain its position as a pioneer in clinical data science. The Chief Technology Officer also collaborates with laboratory facilities to unify molecular sequencing data with patient histories. Shane Colley maintains a focus on technical excellence, driving the continuous evolution of the platform to support complex medical diagnostics and the long-term advancement of precision medicine across the healthcare industry.

Janelle Okrzesik, the Business Development Director, Tempus Compass & Chief Revenue Officer, Oncology Trials, Ai & Real-World Data at Tempus, executes the commercial strategy for oncology trials and real-world data initiatives. Overseeing revenue growth across these specialized sectors, the Chief Revenue Officer ensures that the company's diagnostic tools reach clinical research organizations and pharmaceutical partners. This leadership role involves identifying new market opportunities for the Tempus Compass platform and driving the adoption of precision-based therapeutic models. By aligning business development efforts with the company's clinical data science capabilities, Okrzesik secures long-term partnerships that enhance the organization's market position. The Chief Revenue Officer also manages the integration of real-world data into clinical workflows to improve patient outcomes. Janelle Okrzesik maintains a focus on financial stability, driving the expansion of the company's oncology portfolio while ensuring that the business meets its ambitious goals for growth and innovation in the healthcare sector.

Donavan Cheng, the Chief Technology Officer, Diagnostics at Tempus, directs the technological advancements within the company's state-of-the-art laboratory facilities. Overseeing the integration of advanced genomic sequencing with the broader data platform, the Chief Technology Officer ensures that molecular diagnostics provide actionable insights for clinical practitioners. This leadership role involves developing the proprietary sequencing technologies that allow for the creation of comprehensive, multimodal patient profiles. By bridging the gap between laboratory science and algorithmic analysis, Cheng enables the organization to identify hidden diagnostic risks and therapeutic correlations. The Chief Technology Officer also collaborates with the broader engineering team to ensure that diagnostic data flows seamlessly into the company's predictive models. Donavan Cheng maintains a focus on technical innovation, driving the development of next-generation diagnostic tools that support the company's commitment to precision medicine and the transformation of how doctors approach complex pathologies.